FDA approves Roche's West Nile Virus test
This article was originally published in Clinica
Executive Summary
Ending Gen-Probe's monopoly on the US market, the FDA has approved Roche Diagnostics' biologics license application (BLA) for its cobas TaqScreen West Nile Virus (WNV) test for screening donated blood.